Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Bae, Eun Hui ^a   Choi, Hong Sang ^a   Joo, Soo Yeon ^a   Kim, In Jin ^a   Kim, Chang Seong ^a   Choi, Joon Seok ^a   Ma, Seong Kwon ^a   Lee, JongUn ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 ETHYLCHENODEOXYCHOLIC ACID; CHENODEOXYCHOLIC ACID DERIVATIVE; CISPLATIN; CYTOKINE; FARNESOID X RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SHP PROTEIN; SMAD PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY CELL; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RENAL PROTECTION; SIGNAL TRANSDUCTION; URINARY CAST;

ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANIMALS; CHENODEOXYCHOLIC ACID; CISPLATIN; DNA PRIMERS; EPITHELIAL-MESENCHYMAL TRANSITION; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899917034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086553     Document Type: Article

References (30)

1. Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34: 1522-1534. (Pubitemid 28446332)
2. Park JW, Cho JW, Joo SY, Kim CS, Choi JS, et al. (2012). Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. Eur J Pharmacol 683: 301-309.
3. Yamate J, Tatsumi M, Nakatsuji S, Kuwamura M, Kotani T, et al. (1995) Immunohistochemical observations on the kinetics of macrophages and myofibroblasts in rat renal interstitial fibrosis induced by cis-diamminedichloroplatinum. J Comp Pathol 112: 27-39.
4. Yamate J, Machida Y, Ide M, Kuwamura M, Kotani T, et al. (2005) Cisplatin-induced renal interstitial fibrosis in neonatal rats, developing as solitary nephron unit lesions. Toxicol Pathol 33: 207-217. (Pubitemid 40381448)
5. Jiang M, Wei Q, Wang J, Du Q, Yu J, et al. (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25: 4056-4066. (Pubitemid 44024868)
6. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, et al. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81: 687-693.
7. Claudel T, Sturm E, Kuipers F, Staels B (2004) The farnesoid X receptor: a novel drug target? Expert Opin Investing Drugs 13: 1135-1148. (Pubitemid 39242737)
8. Hu Z, Ren L, Wang C, Liu B, Song G (2012) Effect of chenodeoxycholic Acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed wistar rats. Kidney Blood Press Res 36: 85-97.
9. Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, et al. (2007) Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 56: 2485-2493. (Pubitemid 47523255)
10. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, et al. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Molecular cell 6: 507-515.
11. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, et al. (2000)A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular cell 6: 517-526.
12. Seol W, Choi HS, Moore DD (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272: 1336-1339. (Pubitemid 26199974)
13. Jung GS, Kim MK, Choe MS, Lee KM, Kim HS, et al. (2009) The orphan nuclear receptor SHP attenuates renal fibrosis. J Am Soc Nephrol 20: 2162-2170.
14. Yuk JM, Shin DM, Lee HM, Kim JJ, Kim SW, et al. (2011) The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nature immunol 12: 742-751.
15. Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, et al. (2004) Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal physiol 286: F922-F935. (Pubitemid 38508993)
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
17. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, et al. (1998) Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol 9: 620-631.
18. Rosenau C, Emery D, Kaboord B, Qoronfleh MW (2004) Development of a high-throughput plate-based chemiluminescent transcription factor assay. J Biomol Screen 9: 334-342.
19. Trotter KW, Archer TK (2004) Reconstitution of glucocorticoid receptor-dependent transcription in vivo. Mol Cell Biol 24: 3347-3358. (Pubitemid 38452078)
20. Kim YD, Park KG, Lee YS, Park YY, Kim DK, et al. (2008) Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57: 306-314.
21. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, et al. (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55: 2502-2509. (Pubitemid 44871150)
22. Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, et al. (2012) Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor kappaB signaling. J Pharmacol Exp Ther 341: 725-734.
23. Guijarro C, Egido J (2001) Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59: 415-424. (Pubitemid 32157906)
24. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
25. Rinna A, Forman HJ (2008) SHP-1 inhibition by 4-hydroxynonenal activates Jun N-terminal kinase and glutamate cysteine ligase. Am J Respir Cell Mol Biol 39: 97-104. (Pubitemid 351883963)
26. Ge Q, Moir LM, Black JL, Oliver BG, Burgess JK (2010) TGF-beta1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2/3. J Cell Physiol 225: 846-854.
27. Ma FY, Flanc RS, Tesch GH, Han Y, Atkins RC, et al. (2007) A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 18: 472-484. (Pubitemid 46193313)
28. Alcorn JF, van der Velden J, Brown AL, McElhinney B, Irvin CG, et al. (2009) c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 40: 422-432.
29. Bottinger EP, Bitzer M (2002) TGF-beta signaling in renal disease. J Am Soc Nephrol 13: 2600-2610.
30. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011. (Pubitemid 26097194)